jade_guanyin

Total Rating:
0 / 0

1 Comment

    • Mon Feb 25th 22:51 PM | Rating: 0 0
      Commented on:
      New China Biopharma Investments
      "Because the target is listed on the Hong Kong exchange, the company will not require regulatory approval. "

      As for the above stated remarks made on SHA, just a minor correction, the targetted company is NOT a public company listed in HK Stock Exchange.

      Jade @ Beijing
      View article »
Contribute an Article Become a Seeking Alpha Contributor